A Closer Look at Carestream's Lux 35 Detector
The portability and durability of the device may make it an emerging option for bedside imaging.
Offering an array of promising benefits including quality imaging, usability across devices and enhanced portability due to lighter weight and an ergonomic design, Carestream’s Lux 35 Detector appears to check off a number of boxes for busy radiologists.
In a recent interview at RSNA 2021, Diagnostic Imaging sat down with Jill Hamman, the global product marketing manager for X-ray solutions for Carestream, to discuss the advantages of the Lux 35 Detector. Watch below:
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
